-
1
المؤلفون: David Martin, Jonathan Inselman, Konstantinos C. Siontis, Mary Ross Southworth, Che Ngufor, Karl A. Nath, Rima Izem, Xiaoxi Yao, David J. Graham, Nilay Shah, Nihar R. Desai, Aliza Thompson, Joseph S. Ross, Brahmajee K. Nallamothu, Peter A. Noseworthy, Rajiv Saran
المصدر: Circ Cardiovasc Qual Outcomes
مصطلحات موضوعية: Male, medicine.medical_specialty, Comparative Effectiveness Research, Time Factors, Databases, Factual, Pyridones, Renal function, Administration, Oral, Hemorrhage, Kidney, Risk Assessment, Antithrombins, Article, Decreased kidney function, Rivaroxaban, Risk Factors, Internal medicine, Atrial Fibrillation, Medicine, Humans, In patient, Renal Insufficiency, Chronic, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Antagonist, Warfarin, Anticoagulants, Atrial fibrillation, Middle Aged, medicine.disease, United States, Dabigatran, medicine.anatomical_structure, Treatment Outcome, Cardiology, Pyrazoles, Female, Cardiology and Cardiovascular Medicine, business, medicine.drug, Factor Xa Inhibitors, Glomerular Filtration Rate
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47f9943384b225b7d1e3b25453b39504
https://pubmed.ncbi.nlm.nih.gov/33012172